If the science is so derisked why don’t they start another confirmatory study right now with a new trial design? Doesn’t mean the drug can’t be approved with current study through AA. Why haven’t they received BT status already? They will have to run a PMR regardless. Nothing is derisked until we see the published data. Right now the board is still trying to come up with missing pieces in the data they’ve presented.
Market Data 
Markets 
AI
